Brazzaville, 15 February 2010 – Twenty five experts from WHO, the US President's Emergency Plan For AIDS Relief (PEPFAR) and the US Centers for Disease Control met in Brazzaville from 4-5 February to discuss how countries in the Africa could be assisted to review and adapt their antiretroviral therapy (ART) guidelines in line with the 2009 WHO recommendations on treatment of HIV infected children, adults and adolescents, as well as prevention of maternal to child transmission of HIV and infant feeding in the context of HIV.
The specific objectives of the planning meeting were to:
The meeting adopted detailed recommendations related to the stage at which stage HIV-infected persons including infected children, adults and adolescents and pregnant women should be placed on ART. Participants also adopted recommendations on infant feeding as they relate to HIV-infected mothers and HIV-exposed infants.
The key changes that are expected to result from adapting the revised 2009 WHO ART Guidelines in countries include: earlier diagnosis and treatment of HIV for a prolonged and healthier life; greater use of more patient-friendly treatment regimens; expanded laboratory testing to improve the quality of HIV treatment and care; placement of a larger group of HIV-positive pregnant women on ART for the benefit of both mother and the prevention HIV transmission to the child during pregnancy, and breastfeeding of HIV-exposed infants for a longer period.
According to a report on the meeting, the implications of the 2009 WHO guidelines are that countries will be treating significantly larger numbers of HIV positive patients. This means that people will live longer and more fulfilling lives. On the other hand, there are significant cost implications of the revision of the WHO ART Guidelines. For example, initiating ART earlier may also present adherence challenges and the increased pre-ART care and need for laboratory testing which are bound to challenge the weak health systems in the Region.
The meeting recommended that the WHO Regional Office for Africa should:
For more information, please contact:
Dr Rui Vaz, Tel : + 47- 241-39427
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Samuel T Ajibola, Tel: + 47 241 39378
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it